🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the efficacy and safety of the combi...
Status
Completed
Location
University of South Alabama, Mitchell Cancer Institute ( Site 0065)
Start Date
2019-05-02
Trial ID
NCT03834506
Treatments Being Tested
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
The purpose of this study is to evaluate the safety and efficacy of pembrol...
Status
Completed
Location
St Joseph Heritage Healthcare-Oncology ( Site 0004)
Start Date
2021-10-07
Trial ID
NCT05008224
This is a phase II, single arm, multi-centre study to assess the efficacy o...
Status
Active Not Recruiting
Location
Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum
Start Date
2022-02-22
Trial ID
NCT04575961
Treatments Being Tested
This study is being done to find out if a new medicine called PF-08634404, ...
Status
Recruiting
Location
Pioneer Research Center
Start Date
2026-01-06
Trial ID
NCT07222566
Treatments Being Tested
Immunotherapeutic approaches recently have demonstrated clinical efficacy i...
Status
Recruiting
Location
Aix-en-Provence - CH
Start Date
2022-05-02
Trial ID
NCT05255302
Treatments Being Tested
The main purpose of this study is to see if Pembrolizumab in combination wi...
Status
Active Not Recruiting
Location
Indiana University
Start Date
2016-05-31
Trial ID
NCT02755272
Treatments Being Tested
The primary scientific question of interest of this study is whether the co...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-09-15
Trial ID
NCT05809895
Treatments Being Tested
The PRINCESS study is a hypothesis-generating, interventional, open-label, ...
Status
Unknown
Location
Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo
Start Date
2021-12-02
Trial ID
NCT05821751
Treatments Being Tested
This phase I trial studies the side effects of pembrolizumab in treating pa...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2016-04-04
Trial ID
NCT02595866